Multiple sources discuss the current state and future trajectory of artificial intelligence in drug discovery. While AI has shown promise in accelerating the identification and development of new medicines, its real-world impact and widespread adoption are still evolving. The field faces challenges in translating AI-driven insights into tangible clinical successes and requires continued innovation and collaboration. AI
IMPACT Assesses the real-world impact and challenges of AI in accelerating pharmaceutical research and development.
RANK_REASON The cluster aggregates multiple articles discussing the current state and future of AI in drug discovery, rather than announcing a specific new release or event.
Read on Mastodon — fosstodon.org →
- drug discovery
- science
- AlphaFold
- Atomwise
- BenevolentAI
- Exscientia
- Google DeepMind
- Insilico Medicine
- Isomorphic Labs
- Nature
- NVIDIA
- Schrödinger
AI-generated summary · Google Gemini · from 5 sources. How we write summaries →